DE19850445A1 - Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen - Google Patents
Arzneimittel zur topischen Behandlung entzündlicher DarmerkrankungenInfo
- Publication number
- DE19850445A1 DE19850445A1 DE19850445A DE19850445A DE19850445A1 DE 19850445 A1 DE19850445 A1 DE 19850445A1 DE 19850445 A DE19850445 A DE 19850445A DE 19850445 A DE19850445 A DE 19850445A DE 19850445 A1 DE19850445 A1 DE 19850445A1
- Authority
- DE
- Germany
- Prior art keywords
- medicament according
- drug
- core
- metronidazole
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19850445A DE19850445A1 (de) | 1998-11-02 | 1998-11-02 | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
PCT/EP1999/008191 WO2000025756A2 (fr) | 1998-11-02 | 1999-10-28 | Medicament pour le traitement topique de maladies intestinales inflammatoires |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19850445A DE19850445A1 (de) | 1998-11-02 | 1998-11-02 | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
DE19850445A1 true DE19850445A1 (de) | 2000-05-04 |
Family
ID=7886406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19850445A Withdrawn DE19850445A1 (de) | 1998-11-02 | 1998-11-02 | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE19850445A1 (fr) |
WO (1) | WO2000025756A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20010301A2 (en) * | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
US7928132B2 (en) * | 2004-08-06 | 2011-04-19 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
ITMI20041295A1 (it) | 2004-06-25 | 2004-09-25 | Cosmo Spa | Composizioni farmaceutiche antimicrobiche orali |
US20130259947A1 (en) * | 2010-11-29 | 2013-10-03 | Dr. Reddy's Laboratories Ltd. | Oral metronidazole pharmaceutical compositions |
GB201210184D0 (en) * | 2012-06-11 | 2012-07-25 | Univ Leuven Kath | Formulations of metronidazole for the treatment of pouchitis |
WO2015066490A1 (fr) | 2013-10-31 | 2015-05-07 | Ohio University | Prévention et traitement de stéatose hépatique non alcoolique |
WO2016010611A1 (fr) | 2014-07-18 | 2016-01-21 | Ohio University | Procédés et compositions pour modifier l'activité de gsk-3 |
EP3244890A4 (fr) | 2014-12-20 | 2018-11-21 | Gregg, John Malcolm Hall | Synthèse de médicament antimicrobien et compositions thérapeutiques |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995020383A1 (fr) * | 1994-01-27 | 1995-08-03 | G.D. Searle & Co. | Compositions de metronidazole a liberation modifiee et leurs procedes de fabrication et d'utilisation |
WO1997002020A1 (fr) * | 1995-07-05 | 1997-01-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Composition pharmaceutique administrable par voie orale contenant des agents actifs antimicrobiens et du pantoprazole a liberation differee |
WO1998005303A1 (fr) * | 1996-08-02 | 1998-02-12 | Farmigea S.P.A. | Complexes bioadhesifs de medicaments antifongiques ou antiprotozoaires du type polycarbophil et azole |
WO1998011879A1 (fr) * | 1996-09-19 | 1998-03-26 | Depomed, Inc. | Formes galeniques orales retenues dans l'estomac, pour la liberation controlee de medicaments faiblement solubles et de substance insoluble |
WO1998052547A1 (fr) * | 1997-05-24 | 1998-11-26 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Microspheres de retention gastrique a liberation regulee assurant une meilleure administration de medicaments |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3650787T2 (de) * | 1985-06-13 | 2006-11-16 | Dr. Barry James Marshall | Pharmazeutische Zusammensetzung zur Behandlung gastrointestinaler Beschwerden, die Wismut und ein antimikrobielles Mittel enthält |
MX9605419A (es) * | 1994-05-06 | 1997-12-31 | Pfizer | Formas de dosificacion de liberacion controlada de azitromicina. |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
DE19732903A1 (de) * | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
ES2224428T3 (es) * | 1997-09-26 | 2005-03-01 | Celltech Pharma Europe Limited | Composicion farmnaceutica para el tratamiento de la enfermedad inflmatoria intestinal. |
-
1998
- 1998-11-02 DE DE19850445A patent/DE19850445A1/de not_active Withdrawn
-
1999
- 1999-10-28 WO PCT/EP1999/008191 patent/WO2000025756A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995020383A1 (fr) * | 1994-01-27 | 1995-08-03 | G.D. Searle & Co. | Compositions de metronidazole a liberation modifiee et leurs procedes de fabrication et d'utilisation |
WO1997002020A1 (fr) * | 1995-07-05 | 1997-01-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Composition pharmaceutique administrable par voie orale contenant des agents actifs antimicrobiens et du pantoprazole a liberation differee |
WO1998005303A1 (fr) * | 1996-08-02 | 1998-02-12 | Farmigea S.P.A. | Complexes bioadhesifs de medicaments antifongiques ou antiprotozoaires du type polycarbophil et azole |
WO1998011879A1 (fr) * | 1996-09-19 | 1998-03-26 | Depomed, Inc. | Formes galeniques orales retenues dans l'estomac, pour la liberation controlee de medicaments faiblement solubles et de substance insoluble |
WO1998052547A1 (fr) * | 1997-05-24 | 1998-11-26 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Microspheres de retention gastrique a liberation regulee assurant une meilleure administration de medicaments |
Non-Patent Citations (2)
Title |
---|
Derwent Abstract, Ref. 98-437043/37 zu WO 9832427 A1 * |
PERITI,Piero, et.al.: Current Chemotherapy and Immunotherapy, American Society for Microbiology, Washington, D.C., U.S.A., Vol.1, 1981, S.111-113 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000025756A3 (fr) | 2000-07-27 |
WO2000025756A2 (fr) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0977557B1 (fr) | Formulation de type pellet, s'utilisant dans le traitement du tractus intestinal | |
DE69624910T2 (de) | Orale pharmazeutische dosierungsformen die einen protonenpumpeninhibitor und ein prokinetisches mittel enthalten | |
DE69717312T2 (de) | Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden | |
DE69720985T2 (de) | Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung | |
DE69901570T2 (de) | Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe | |
EP0068191B1 (fr) | Formes orales du dipyridamole | |
DE60221691T2 (de) | Tamsulosin tabletten ohne nahrungsmitteleffekt | |
EP0934058B1 (fr) | Forme stable de medicament pour administration par voie orale, a base de derives de benzimidazole comme principe actif, et son procede de productionn | |
DE60222687T3 (de) | Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz | |
EP1113787B1 (fr) | Preparations pharmaceutiques a liberation controlee en fonction de l'agitation et leur procede de production | |
DE102004062475A1 (de) | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung | |
DE602006000819T2 (de) | Dipyridamol enthaltende Zusammensetzungen mit verlängerter Freisetzung und Verfahren zu deren Herstellung | |
EP0682945A2 (fr) | Préparation orale à effet retard | |
EP1017392B1 (fr) | Formulation medicamenteuse a liberation controlee du principe actif | |
DE202006020331U1 (de) | Neue, pharmazeutische modifizierte Freisetzungs-Dosisform Cyclooxygenase-Enzym-Inhibitor | |
CH705273B1 (de) | Pharmazeutische Zusammensetzung – umfassend Hydromorphon und Naloxon. | |
EP0250648A2 (fr) | Préparation pharmaceutique pour la libération retardée de l'ibuprofène | |
EP0994696B1 (fr) | Preparations pharmaceutiques a liberation controlee contenant un inhibiteur de l'enzyme de conversion de l'angiotensine comme principe actif | |
DE102009033621A1 (de) | Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen | |
DE10209979A1 (de) | Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung | |
EP1315481A1 (fr) | Medicament pour le traitement de maladies intestinales | |
DE19850445A1 (de) | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen | |
WO2001068056A1 (fr) | Glucocorticoide dans une formulation a liberation modifiee | |
WO2000048577A1 (fr) | Medicament destine au traitement ou a la prevention du cancer de l'intestin | |
DE2950154C2 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OM8 | Search report available as to paragraph 43 lit. 1 sentence 1 patent law | ||
8139 | Disposal/non-payment of the annual fee |